Risk of diabetic retinopathy and retinal neurodegeneration in individuals with type 2 diabetes: Beichen Eye Study

被引:2
|
作者
Yang, Zhengwei
Liu, Qingyan
Wen, Dejia
Yu, Zihao
Zheng, Chuanzhen
Gao, Fei
Chen, Chen
Hu, Liying
Shi, Yu
Zhu, Xiuqing
Liu, Juping [1 ]
Shao, Yan [1 ]
Li, Xiaorong [1 ]
机构
[1] Tanjin Med Univ, Eye Inst, Eye Hosp, Natl Clin Res Ctr Ocular Dis,Tianjin Key Lab Retin, Tianjin, Peoples R China
来源
FRONTIERS IN ENDOCRINOLOGY | 2023年 / 14卷
关键词
risk factors; type 2 diabetes mellitus; diabetic retinopathy; retinal neurodegeneration; macular ganglion cell-inner plexiform layer; risk of diabetic retinopathy and retinal neurodegeneration; LAYER THICKNESS; PREVALENCE; PROGRESSION; POPULATION; CLASSIFICATION; EPIDEMIOLOGY; UK;
D O I
10.3389/fendo.2023.1098638
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveOur aim was to evaluate associations of different risk factors with odds of diabetic retinopathy (DR) diagnosis and retinal neurodegeneration represented by macular ganglion cell-inner plexiform layer (mGCIPL). MethodsThis cross-sectional study analyzed data from individuals aged over 50 years examined between June 2020 and February 2022 in the community-based Beichen Eye Study on ocular diseases. Baseline characteristics included demographic data, cardiometabolic risk factors, laboratory findings, and medications at enrollment. Retinal thickness in both eyes of all participants was measured automatically via optical coherence tomography. Risk factors associated with DR status were investigated using multivariable logistic regression. Multivariable linear regression analysis was performed to explore associations of potential risk factors with mGCIPL thickness. ResultsAmong the 5037 included participants with a mean (standard deviation, SD) age of 62.6 (6.7) years (3258 women [64.6%]), 4018 (79.8%) were control individuals, 835 (16.6%) were diabetic individuals with no DR, and 184 (3.7%) were diabetic individuals with DR. The risk factors significantly associated with DR status were family history of diabetes (odds ratio [OR], 4.09 [95% CI, 2.44-6.85]), fasting plasma glucose (OR, 5.88 [95% CI, 4.66-7.43]), and statins (OR, 2.13 [95% CI, 1.03-4.43]) relative to the control individuals. Compared with the no DR, diabetes duration (OR, 1.17 [95% CI, 1.13-1.22]), hypertension (OR, 1.60 [95% CI, 1.26-2.45]), and glycated hemoglobin A1C (HbA1c) (OR, 1.27 [95% CI, 1.00-1.59]) were significantly correlated with DR status. Furthermore, age (adjusted beta = -0.19 [95% CI, -0.25 to -0.13] mu m; P < 0.001), cardiovascular events (adjusted beta = -0.95 [95% CI, -1.78 to -0.12] mu m; P = 0.03), and axial length (adjusted beta = -0.82 [95% CI, -1.29 to -0.35] mu m; P = 0.001) were associated with mGCIPL thinning in diabetic individuals with no DR. ConclusionMultiple risk factors were associated with higher odds of DR development and lower mGCIPL thickness in our study. Risk factors affecting DR status varied among the different study populations. Age, cardiovascular events, and axial length were identified as potential risk factors for consideration in relation to retinal neurodegeneration in diabetic patients.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Significance of microalbuminuria in predicting the risk of diabetic retinopathy in type 2 diabetes mellitus patients
    Zhang, Xuelin
    Liu, Xia
    Huang, Fang
    Li, Dongmei
    Wu, Xueyun
    Li, Jun
    Chen, Xinhuang
    Liao, Weijia
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (05): : 8208 - 8215
  • [42] Predictors of Diabetic Retinopathy in Type 2 Diabetes: A Cross-Sectional Study
    Ivanescu, Adriana
    Popescu, Simona
    Ivanescu, Radu
    Potra, Monica
    Timar, Romulus
    BIOMEDICINES, 2024, 12 (08)
  • [43] C-reactive protein and diabetic retinopathy in Chinese patients with type 2 diabetes mellitus
    Yang, Xiu-Fen
    Deng, Yu
    Gu, Hong
    Lim, Apiradee
    Snellingen, Torkel
    Liu, Xi-Pu
    Wang, Ning-Li
    Domalpally, Amitha
    Danis, Ronald
    Liu, Ning-Pu
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2016, 9 (01) : 111 - 118
  • [44] The relationship between diabetic retinopathy and diabetic nephropathy in type 2 diabetes
    Wang, Qian
    Cheng, Haimei
    Jiang, Shuangshuang
    Zhang, Li
    Liu, Xiaomin
    Chen, Pu
    Liu, Jiaona
    Li, Ying
    Liu, Xiaocui
    Wang, Liqiang
    Li, Zhaohui
    Cai, Guangyan
    Chen, Xiangmei
    Dong, Zheyi
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [45] Risk of retinal neovascularization in the second eye in patients with proliferative diabetic retinopathy
    Vesteinsdottir, Edda
    Bjornsdottir, Sigridur
    Hreidarsson, Astradur B.
    Stefansson, Einar
    ACTA OPHTHALMOLOGICA, 2010, 88 (04) : 449 - 452
  • [46] Retinopathy risk calculators in the prediction of sight-threatening diabetic retinopathy in type 2 diabetes: A FIELD substudy
    Rao, Benjamin N.
    Quinn, Nicola
    Januszewski, Andrzej S.
    Peto, Tunde
    Brazionis, Laima
    Aryal, Nanda
    O'Connell, Rachel L.
    Li, Liping
    Summanen, Paula
    Scott, Russell
    O'Day, Justin
    Keech, Anthony C.
    Jenkins, Alicia J.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 186
  • [47] Photodiagnosis of diabetic eye disease-The Beichen Eye Study
    Yeung, Carly Sin Ki
    Au, Sunny Chi Lik
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2025, 51
  • [48] Prevalence and Risk Factors of Retinopathy in Type 1 Diabetes: A Cross-Sectional Study
    Berrabeh, Soumiya
    Elmehraoui, Ouafae
    Benouda, Siham
    Assarrar, Imane
    Rouf, Siham
    Latrech, Hanane
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
  • [49] Correlations between Retinal Arterial Morphometric Parameters and Neurodegeneration in Patients with Type 2 Diabetes Mellitus with No or Mild Diabetic Retinopathy
    Damian, Ioana
    Nicoara, Simona Delia
    MEDICINA-LITHUANIA, 2021, 57 (03):
  • [50] Differences in Risk Factors for Diabetic Retinopathy in Type 1 and Type 2 Diabetes Mellitus Patients in North-East Poland
    Matuszewski, Wojciech
    Stefanowicz-Rutkowska, Magdalena M.
    Szychlinska, Magdalena
    Bandurska-Stankiewicz, Elzbieta
    MEDICINA-LITHUANIA, 2020, 56 (04):